FDA could approve Pfizer vaccine for kids ages 6 months to 5 years by the end of February | MSNBC
CEID Founding Director Dr. Nahid Bhadelia spoke with MSNBC’s Yasmin Vossoughian about possible FDA approval for Pfizer’s Covid-19 vaccine for children aged 6 months to 5 years. Watch the full clip here.
What causes long Covid? Scientists are zeroing in on the answer. | Vox
CEID Founding Director Dr. Nahid Bhadelia offers insights on long COVID: “…No one knows exactly how many people have or had long Covid. Estimates so far are ‘wildly disparate’ in part because researchers define the condition differently and because the people seeking care may only be a small portion of those affected, said Nahid Bhadelia, […]
Long COVID Is Real, and Many Real Questions Remain | WebMD
This article shares insights made by CEID Founding Director Dr. Nahid Bhadelia during a recent Infectious Diseases Society of America media briefing on long COVID: “…Unanswered questions include: Does an autoimmune reaction drive long COVID? Does the coronavirus linger in reservoirs within the body and reactivate later? What protection against long COVID do vaccines and treatments offer, […]
Who’s at Risk for Long COVID? A Study Says These 4 Factors May Predict Persistent Symptoms | Health
CEID Founding Director Dr. Nahid Bhadelia is quoted in a Health article about long COVID: “…Capturing the true burden of long COVID is complicated by the lack of access to COVID testing, particularly in communities of color, and by the lack of diversity in research studies, Dr. Bhadelia points out. The lack of a standard […]
Dr. Nahid Bhadelia Featured on The Beat with Ari Melber
CEID Founding Director Dr. Nahid Bhadelia spoke with Ari Melber about where we are two years into the COVID pandemic. Read the full transcript here.
Pandemic prevention center to stockpile antibodies in Rockville | Washington Times
The Washington Times highlighted CEID’s partnership with Connected DMV’s Global Pandemic Prevention and Biodefense Center: “Dr. Nahid Bhadelia, an infectious diseases specialist, represents the Boston University School of Medicine on the steering committee. The university’s Center for Emerging Infectious Diseases Policy and Research, which she founded, said in a statement that it ‘will provide expertise […]
How will we know when the COVID-19 pandemic is over? | Poynter
CEID Founding Director Dr. Nahid Bhadelia discusses COVID-19 endemicity in Poynter. “A lot will depend on whether the virus has faded enough for society to function under the status quo, said Dr. Nahid Bhadelia, the founding director of Boston University’s Center for Emerging Infectious Diseases Policy and Research. ‘Can our society function if (the) current […]
Evergrande reneges on multimillion-dollar pledge to Harvard-led COVID project, another stumble in its ties to school | Boston Globe
CEID Founding Director Dr. Nahid Bhadelia discusses the Harvard-led Consortium in The Boston Globe. “The consortium’s galvanizing investment is ‘important for patients, for the region, for all of us to return to normalcy,’ said Dr. Nahid Bhadelia, co-leader of the consortium’s working group on long COVID and director of the Boston University Center for Emerging […]
Transcript: The 11th Hour, 1/14/22 | MSNBC
CEID Founding Director Dr. Nahid Bhadelia joins MSNBC to provide an update on the omicron variant. “I think that what we`re seeing is in some states who are reaching the peak, and the modeling in most cases says that by the end of January, a lot of states are not yet at the peak. And […]
Making sense of the COVID pandemic’s omicron phase | WBUR
CEID Founding Director Dr. Nahid Bhadelia talks about how we should measure the pandemic during the omicron phase. “I don’t think there’s ever going to be a single metric that we follow and say that’s the only one that we need to look at. I think all the metrics always give you information and eyes […]